-x-95-(h).jpg)
What Would You Do? An Interactive and Evidence-Based Educational Session on MS Treatment Approaches
Released On
December 13, 2022
Expires On
December 13, 2023
Media Type
Internet
Completion Time
60 minutes
Specialty
Neurology, Pharmacy, Primary Care
Topic(s)
Multiple Sclerosis
Scroll to the Bottom of this Information to Begin this Course
This activity is jointly provided by the Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education.
This activity is supported by independent educational grants from Biogen and Genentech.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
- Nurses — maximum of 1.0 contact hour(s) of nursing continuing professional development (NCPD)
- Pharmacists — maximum of 1.0 contact hour(s) of continuing pharmacy education credit
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed to meet the educational needs of neurologists, advanced practice nurses, physician assistants, nurses, pharmacists, and other members of the healthcare professional team who care for people with MS.
Program Overview
An interactive, case-based activity designed to challenge learners' thinking and decision-making skills, while providing evidence and expert insights related to considerations in the care of people living with MS.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Discuss patient-specific considerations that affect decisions for initiating or switching treatment for patients with MS
- Review disease-modifying and symptomatic therapies for MS
- Identify socio-economic, geographic, and ethnocultural considerations in the care of people living with MS
Faculty
James Bowen, MD
Multiple Sclerosis Center, Swedish Neuroscience InstituteLe Hua, MD
Lou Ruvo Center for Brain HealthCleveland Clinic
Physician Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Credit Designation
The CMSC designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The CMSC designates this activity for a maximum of 1.0 NCPD credit (1.0 in the area of pharmacology).
Pharmacists Credit Designation
This knowledge-based activity, UAN JA4008165-9999-22-038-H01-P, qualifies for 1.0 contact hours (0.10 CEUs) of continuing pharmacy education credit.
All other healthcare professionals completing this course will be issued a statement of participation.
Disclosures of Conflicts of Interest
It is the policy of the Consortium of Multiple Sclerosis Centers (CMSC) to ensure balance, independence, objectivity, and scientific rigor in all educational activities. All faculty, planning committee members, content reviewers, and staff participating in this activity have disclosed any relevant financial relationships they or their significant other have had within the previous 12 months with manufacturers of any commercial products/devices and/or providers of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. All presentations were reviewed by an independent clinician with no relevant financial relationships for the purpose of resolution of any identified conflict of interest and a determination of evidence-base and fair balance.
Faculty Disclosures
- James Bowen, MD
-
- Consulting Fee: Biogen IDEC, EMD Serono, Genentech, Novartis Pharmaceuticals Corporation, TG Therapeutics
- Speakers Bureau: Biogen IDEC, EMD Serono, Genentech, Novartis Pharmaceuticals Corporation
- Contracted Research: AbbVie, Biogen IDEC, Bristol Myers Squibb, Genentech, Genzyme, Novartis Pharmaceuticals Corporation, Roche, Sanofi, TG Therapeutics
- Ownership Interest: Amgen
- Le Hua, MD
-
- Consulting Fee: Alexion, EMD Serono, Genentech, Genzyme, Greenwich, Horizon, Novartis Pharmaceuticals Corporation, TG Therapeutics
- Speakers Bureau: Bristol Myers Squibb
- Contracted Research: AbbVie, Adamas, Biogen, Bristol Myers Squibb, EMD Serono, Genentech, Genzyme, Novartis Pharmaceuticals Corporation, TG Therapeutics
Activity Staff Disclosures
June Halper, MSN, APN-C, MSCN, FAAN, and Laurie Scudder, DNP, NP, served as planners and reviewers and have disclosed no relevant financial relationships.
All other planners, reviewers, staff, and members of the Continuing Professional Education Committee at the Consortium of Multiple Sclerosis Centers who control content have disclosed no relevant financial relationships.
The planners, reviewers, editors, staff, continuing education (CE) committee, and other members at Catamount Medical Education who control content have disclosed no relevant financial relationships.
Instructions for Participation and Credit
There are no fees for participating and receiving CE credit for this enduring activity. To receive CE credit, participants must:
- Complete the pre-test
- Study the educational activities
- View the videos
- Complete the post-test and evaluation form
Upon completion of the evaluation, your certificate will be made available immediately. Click on View Certificate and print the certificate for your records.
Percentage required to pass post-test: 75%
The estimated time to complete the activity is 60 minutes.
This activity was originally released on December 13, 2022, and is eligible for credit through December 13, 2023.
Course Viewing Requirements
This site is best viewed with an HTML5 compatible browser. You can visit the independent (3rd-party) site www.whatismybrowser.com to determine if you have the latest version of your browser.
Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player.
Our Policy on Privacy
The Consortium of Multiple Sclerosis Centers and Catamount Medical Education, LLC, respect your privacy. All personal information that is provided to Catamount Medical Education, LLC, is protected and will not be sold to a third party for commercial purposes. All personally identifiable information contained in the Catamount Medical Education, LLC, registration databases is treated as confidential and will be used only for the purposes stated in this policy, except where required by law. Catamount Medical Education, LLC, maintains user databases that contain mailing and user profile information as well as a record of the CME activities viewed and the post-test and evaluation results for CE credit. This information is provided to activity collaborators for the purposes of CE recordkeeping. By participating in this activity, you agree that Catamount Medical Education, LLC, has full permission to provide this information.
Disclosure of Unlabeled Use
CMSC and Catamount Medical Education require CE faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Contact Information
For questions about this activity, please contact Catamount Medical Education at info@catmeded.com.